Aortic thromboembolism (ATE) / Saddle thrombus

Aortic thromboembolism (ATE), commonly known as saddle thrombus, is a devastating and life-threatening cardiovascular emergency that occurs when a blood clot forms in the heart and then travels to lodge at the aortic bifurcation, the point where the main artery (aorta) divides into the two arteries supplying the hind legs. This catastrophic event causes sudden, complete or near-complete obstruction of blood flow to the affected limbs, resulting in acute, severe pain and paralysis. ATE is most commonly associated with underlying heart disease, particularly hypertrophic cardiomyopathy (HCM), which is the most prevalent heart condition in cats. While ATE can affect cats of any age, it most commonly occurs in middle-aged to older cats, typically between eight and twelve years of age, and represents one of the most serious complications of feline cardiac disease.

The development of ATE begins with abnormal blood flow patterns within a diseased heart, most commonly in the enlarged left atrium seen in cats with cardiomyopathy. Turbulent blood flow and areas of stasis allow blood clots to form within the heart chambers. When a portion of this clot breaks free and enters the bloodstream, it travels through the aorta until it reaches a point where the vessel diameter narrows and the clot can no longer pass. The most common site of lodgment is the aortic trifurcation (where the aorta divides), hence the term saddle thrombus, as the clot sits astride this division like a saddle. The clot can also lodge in other locations, including the arteries supplying a single limb, the kidneys, intestines, or brain.

The impact of ATE on a cat's health is profound and immediately apparent. Complete obstruction of blood flow to the hind limbs causes ischemia, meaning the tissues are deprived of oxygen and nutrients. Within minutes of obstruction, the muscles begin to suffer damage, nerves lose function, and without blood flow, tissue death begins. Affected cats experience intense pain and rapidly develop paralysis of the affected limbs. The cardiovascular system is also stressed by the sudden obstruction and the release of toxic substances from the ischemic tissues. Additionally, most cats with ATE have significant underlying heart disease that may cause concurrent problems including congestive heart failure, arrhythmias, and reduced cardiac output. This combination of acute circulatory crisis and underlying cardiac dysfunction creates a true emergency.

Despite its severity, ATE is potentially treatable, though outcomes depend heavily on multiple factors including the extent of circulatory obstruction, the severity of underlying heart disease, how quickly treatment is initiated, and the presence of complications such as congestive heart failure. Emergency treatment focuses on pain management, supportive care, and preventing clot extension while the body attempts to restore circulation through collateral blood vessels or clot dissolution. Some cats survive the acute episode and regain significant function, though recurrence risk remains high in cats with persistent heart disease. Early recognition of ATE symptoms and immediate veterinary care are essential, as delays in treatment worsen outcomes significantly. Cat owners, particularly those whose cats have known heart disease, should be aware of ATE symptoms and prepared to seek emergency care immediately.

The primary cause of aortic thromboembolism in cats is underlying heart disease, with hypertrophic cardiomyopathy (HCM) being responsible for the majority of cases. Cardiomyopathy causes structural changes in the heart that create conditions favorable for blood clot formation. In HCM, the most common feline heart disease, thickening of the heart muscle reduces the size of the heart chambers and impairs normal blood flow. The left atrium, which receives blood returning from the lungs, often becomes enlarged as it struggles to empty into the stiffened left ventricle. This enlarged, dilated left atrium creates areas of sluggish blood flow where clots can form. Other forms of cardiomyopathy, including dilated, restrictive, and unclassified cardiomyopathies, can similarly lead to ATE through various mechanisms that disturb normal cardiac blood flow.

While heart disease itself is not directly inherited as a single gene trait in most cats, genetic factors strongly influence susceptibility to cardiomyopathies that predispose to ATE. Certain breeds, most notably Maine Coons and Ragdolls, have identified genetic mutations associated with hypertrophic cardiomyopathy, and cats inheriting these mutations face elevated risk of both heart disease and its complications including ATE. Other breeds with higher incidences of cardiomyopathy include British Shorthairs, Persians, Birmans, and Sphynx cats. Family history of heart disease or ATE in related cats suggests genetic predisposition. However, ATE can occur in any cat with heart disease, including domestic shorthairs and longhairs with no known breed predisposition.

Environmental and physiological factors can contribute to the conditions that promote clot formation in cats with underlying heart disease. Dehydration concentrates the blood and promotes clotting. Stress, which is common in cats particularly during veterinary visits or significant environmental changes, can trigger sympathetic nervous system activation that may promote clot release from the heart. Anesthesia for surgical procedures can alter blood pressure and flow dynamics, occasionally triggering ATE in cats with undiagnosed heart disease. Diet plays an indirect role, as nutritional factors affecting heart health, particularly taurine levels, historically contributed to cardiomyopathy before routine supplementation of commercial cat foods.

Several risk factors increase the likelihood of ATE in cats with heart disease. The severity and type of cardiac disease significantly influences risk, with marked left atrial enlargement being the most important predictor of ATE development. Cats with spontaneous echocardiographic contrast (smoke) visible in the left atrium on ultrasound, indicating sluggish blood flow, face particularly high risk. Previous ATE episode dramatically increases the likelihood of recurrence. Male cats appear to be affected more commonly than females, though this may reflect their higher incidence of HCM rather than an independent sex-related risk factor. Concurrent conditions that promote a hypercoagulable state, such as certain cancers or chronic inflammatory conditions, may increase risk.

The mechanism of ATE development involves a cascade of events beginning with abnormal conditions within the heart. Virchow's triad, the classic description of factors promoting thrombosis, applies directly to feline ATE: abnormal blood flow (stasis in the enlarged left atrium), abnormal vessel wall (endothelial dysfunction associated with cardiac disease), and abnormal blood composition (hypercoagulability). Platelets aggregate and fibrin deposits form, creating a clot attached to the left atrial wall. When a portion of this clot breaks free, either spontaneously or triggered by changes in heart rhythm or blood pressure, it becomes an embolus traveling through the bloodstream. Upon reaching the aortic bifurcation, the embolus lodges and triggers additional local clot formation. Beyond mechanical obstruction, the clot releases vasoactive substances including serotonin that cause severe constriction of the affected arteries and even distant vessels, worsening ischemia beyond what the mechanical obstruction alone would cause.

The early warning signs of aortic thromboembolism are typically subtle or absent, as the condition usually presents with sudden, dramatic onset rather than gradual development. However, some cats may show signs of underlying heart disease before an ATE episode occurs, including decreased activity, mild respiratory changes, or subtle behavioral changes that owners might not recognize as significant. Cats are exceptionally skilled at hiding illness, and heart disease often remains undetected until a crisis like ATE occurs. Some cats with significant heart disease may show no clinical signs whatsoever until the moment of acute thromboembolism. This makes regular veterinary examinations with cardiac auscultation important for potentially detecting heart disease before devastating complications occur.

The common symptoms of ATE at the time of occurrence are dramatic and unmistakable, representing a true emergency that demands immediate recognition. The classic presentation involves sudden onset of severe distress, vocalization indicating intense pain, and loss of function in the hind legs. Most cats present with complete paralysis of both hind limbs, though if the clot lodges more to one side, only one leg may be affected. The onset is acute, often occurring within minutes, and owners frequently report finding their cat suddenly collapsed or dragging the hind end. Affected cats are typically in obvious distress, may pant or breathe with an open mouth, and show signs of extreme pain including crying, growling, or aggression when touched. The acute crisis is unmistakable and clearly represents an emergency situation.

Behavioral changes during an ATE episode reflect the severe pain and distress the cat experiences. Vocalization is common and may be intense, with yowling or screaming indicating the severity of pain. Some cats become aggressive, biting or scratching when approached due to pain and fear. Others become withdrawn and hide. Affected cats cannot walk normally and may drag their hind legs or lie in an awkward position unable to right themselves. Some cats attempt to crawl using only their front legs. Appetite is absent during the acute crisis, and the cat may refuse to engage with family members. The dramatic change from normal behavior is striking and alarming to owners who witness the event.

Physical signs that owners and veterinarians observe during ATE examination are characteristic and help confirm the diagnosis. The affected hind limbs are paralyzed and have a firm, painful feel to the muscles. A critical finding is the absence of a femoral pulse in the affected legs, as blood cannot flow past the obstruction. The paw pads of affected limbs are typically cold to the touch and may appear pale or cyanotic (bluish) rather than their normal pink color, reflecting the lack of blood flow. The claws may fail to bleed if cut (or are slow to bleed), further demonstrating circulatory compromise. The legs may be extended rigidly rather than having normal muscle tone. Concurrent signs of heart disease or heart failure may be present, including rapid breathing, heart murmur, or abnormal heart rhythm.

Symptom progression in ATE depends on whether treatment is initiated and how well the cat responds. Without treatment, the ischemic limbs undergo progressive tissue damage, with muscle death occurring within hours. Reperfusion injury, which occurs when blood flow is restored to damaged tissues, can cause release of toxins into the bloodstream. Cats may develop signs of shock, with weakness, hypothermia, and cardiovascular collapse. With treatment, some cats stabilize and gradually show signs of improved circulation over hours to days, with warming of the limbs, return of pulses, and gradual improvement in function. Recovery of limb function, if it occurs, typically takes days to weeks and may be incomplete.

Emergency symptoms requiring immediate veterinary attention include the acute onset of the condition itself, which always represents an emergency. Signs of respiratory distress such as open-mouth breathing, blue-tinged gums, or severe rapid breathing indicate possible concurrent congestive heart failure and represent additional life-threatening complications. Complete cardiovascular collapse with extreme weakness, very pale gums, severe hypothermia, or unresponsiveness indicates shock and critical deterioration. Cats showing any combination of sudden hind limb paralysis, severe pain, cold limbs, and respiratory distress should be transported immediately to the nearest emergency veterinary facility, as minutes matter in this condition.

The diagnostic process for aortic thromboembolism typically begins at an emergency veterinary facility where the cat presents with acute hind limb paralysis and distress. Physical examination reveals the classic findings that are highly suggestive of ATE: one or both hind limbs that are paralyzed, painful, cold, and lacking palpable pulses. The veterinarian will assess the extent of limb involvement, checking for any remaining circulation by evaluating pulse quality, limb temperature, paw pad color, and nail bed bleeding. A thorough cardiovascular examination is performed, including auscultation (listening) for heart murmurs, arrhythmias, or signs of fluid accumulation in the lungs. Assessment of the cat's overall condition, including hydration status, temperature, and level of consciousness, helps determine stability and guides immediate treatment decisions.

Diagnostic tests are performed to confirm the diagnosis, assess the severity of the underlying heart disease, and evaluate for complications. Blood tests including a complete blood count and chemistry panel assess organ function and help identify complications such as kidney injury from decreased blood flow or metabolic disturbances from tissue damage. Cardiac biomarkers such as troponin and NT-proBNP may be elevated, indicating heart muscle damage and heart disease respectively. Coagulation tests assess the blood's clotting function. Blood lactate levels may be measured to assess the severity of tissue ischemia. Blood pressure measurement helps evaluate cardiovascular function. Arterial blood gas analysis may reveal metabolic acidosis from inadequate tissue oxygenation.

Imaging studies provide crucial information about the heart and the thrombus. Thoracic radiographs (chest X-rays) evaluate heart size and shape and assess for evidence of congestive heart failure such as pulmonary edema or pleural effusion. Echocardiography (cardiac ultrasound) is the most important imaging modality, allowing visualization of the heart's structure and function, measurement of chamber sizes, assessment of contractility, and potentially direct visualization of thrombus in the heart. The severity of underlying heart disease identified on echocardiography significantly influences prognosis. Doppler ultrasound of the affected limbs can document reduced or absent blood flow. In some cases, advanced imaging such as CT angiography may be used to directly visualize the thrombus and assess its extent.

Differential diagnosis for acute hind limb paralysis in cats includes several other conditions that must be considered, though ATE has a characteristic presentation that usually makes diagnosis straightforward. Spinal cord trauma or disc disease can cause acute paralysis, but affected limbs remain warm with palpable pulses. Spinal tumors may cause paralysis but typically with more gradual onset. Severe diabetic neuropathy can cause hind limb weakness but not the acute onset and circulatory changes of ATE. Thrombosis of the caudal vena cava (a vein) has different characteristics than arterial obstruction. Confirmation of ATE is achieved through the combination of clinical findings (cold, pulseless, paralyzed limbs), evidence of underlying heart disease on examination and imaging, and exclusion of other causes. The classic pentad of ATE includes pain, paralysis, pulselessness, pallor, and poikilothermia (cold limbs).

Emergency treatment for aortic thromboembolism focuses on stabilizing the cat, managing severe pain, and providing supportive care while assessing whether recovery is possible. Pain management is an immediate priority, as ATE causes excruciating pain that contributes to distress and cardiovascular instability. Potent opioid analgesics such as methadone, fentanyl, or hydromorphone are administered, often requiring relatively high doses to achieve adequate pain control. Oxygen supplementation may be provided if there are signs of respiratory compromise. Intravenous fluid therapy is approached cautiously, as many cats with ATE have concurrent heart failure and cannot tolerate aggressive fluid administration. Thermoregulation is important, as hypothermic cats should be gently warmed. Sedation with acepromazine may be beneficial for its anxiolytic effects and potential to improve peripheral blood flow.

Medical management of ATE includes anticoagulant and antiplatelet therapy aimed at preventing clot extension and new clot formation. Heparin, either unfractionated or low molecular weight (such as enoxaparin or dalteparin), is commonly administered to inhibit further clot formation. Aspirin or clopidogrel may be used for their antiplatelet effects. The goal of these medications is not to dissolve the existing clot, which the body must accomplish through its own fibrinolytic mechanisms, but to prevent the situation from worsening. Treatment of concurrent congestive heart failure with diuretics (such as furosemide) may be necessary if pulmonary edema or pleural effusion is present. Management of cardiac arrhythmias, if present, may require specific antiarrhythmic medications. Drugs to support blood pressure and cardiac output may be used in critically ill cats.

Thrombolytic therapy, using drugs that actively dissolve blood clots, represents a more aggressive treatment approach that has been attempted in feline ATE with variable results. Tissue plasminogen activator (tPA) and streptokinase are thrombolytic agents that can dissolve clots but carry significant risks including life-threatening bleeding complications and reperfusion injury when blood flow is suddenly restored to damaged tissues. Due to these risks and inconsistent benefit, thrombolytic therapy is not routinely recommended for feline ATE and is only considered in selected cases at specialized facilities. Rheolytic thrombectomy and other interventional procedures to mechanically remove clots have been reported but are not widely available for cats. The standard approach remains supportive care with anticoagulation rather than active clot dissolution.

Supportive care during the treatment period addresses the multiple needs of critically ill cats with ATE. Nutritional support through syringe feeding or feeding tubes may be necessary for cats unable or unwilling to eat. Bladder management is important, as many affected cats cannot urinate normally; gentle manual bladder expression or temporary urinary catheterization may be required. Physical therapy and limb massage may help maintain muscle condition and promote circulation in recovering limbs. Strict cage rest prevents further injury to compromised limbs. Monitoring includes regular assessment of limb temperature, color, and pulse return, along with repeated cardiac monitoring. Prevention of pressure sores through appropriate bedding and position changes is important for recumbent cats.

Treatment decisions in ATE cases require honest assessment of prognosis and compassionate discussion with owners about realistic expectations. Factors influencing treatment recommendations include the extent of limb involvement (one leg versus both), severity of underlying heart disease, presence of congestive heart failure, the cat's age and overall condition, and response to initial treatment. Some cats show encouraging signs within hours to days, with limbs warming and function beginning to return. Others remain severely affected despite treatment. Euthanasia may be the most humane option for cats with severe heart disease, poor response to treatment, or profound suffering that cannot be adequately controlled. The financial and emotional commitment required for intensive care over days to weeks, with uncertain outcome, must also be considered in treatment decisions.

The recovery timeline for cats surviving an ATE episode varies considerably depending on the severity of the initial event, the extent of tissue damage, and the condition of the underlying heart disease. Some cats show signs of improved circulation within hours of treatment initiation, with limb temperature increasing and pulses becoming detectable. Meaningful return of motor function typically takes longer, usually beginning within one to three days in cats with good recovery potential and continuing to improve over weeks. Maximum recovery of function may not be achieved for four to six weeks or longer, and some cats may have permanent residual deficits. Cats that do not show signs of improved circulation within the first 48 to 72 hours have a poor prognosis for limb recovery.

Post-treatment care for cats recovering from ATE involves multiple aspects of nursing care and medical management. Continued pain management remains important during the recovery phase, though analgesic requirements typically decrease as the acute crisis resolves. Physical rehabilitation, including gentle range of motion exercises and assisted standing, helps maintain muscle mass and promotes functional recovery. Bladder care continues until the cat regains voluntary urination. The recovering limbs require protection from trauma and pressure sores. Nutritional support ensures adequate caloric intake during recovery. Cardiac medications are continued or adjusted based on the underlying heart disease, and anticoagulant or antiplatelet therapy is typically continued long-term to reduce recurrence risk.

Prognosis for cats with ATE depends on multiple factors that influence both survival and quality of life. Immediate survival rates vary but approximately 35 to 50 percent of cats with ATE survive to hospital discharge. However, recurrence rates are high, with approximately 25 to 50 percent of surviving cats experiencing another ATE episode within one year, often fatal. Cats with milder underlying heart disease, single limb involvement, and quick response to treatment have better prognosis. The presence of congestive heart failure, hypothermia, bradycardia, or cardiac arrhythmias at presentation indicates poorer prognosis. Cats that require mechanical ventilation or have evidence of other organ dysfunction face significantly reduced survival rates.

Long-term outlook for cats surviving ATE involves managing both the risk of recurrence and the underlying heart disease. Many cats that recover from ATE can enjoy good quality of life for months to years, though they require ongoing cardiac medication and monitoring. Long-term anticoagulant or antiplatelet therapy with medications such as clopidogrel significantly reduces recurrence risk. Regular cardiac monitoring through periodic echocardiography allows assessment of disease progression. Some cats may have persistent neurological or muscular deficits in the affected limbs, including muscle atrophy, weakness, or abnormal gait, but many adapt well and maintain good quality of life despite these changes. Quality of life assessment considers not only physical function but also comfort, appetite, interaction with family, and overall wellbeing.

Primary prevention of aortic thromboembolism focuses on identifying and managing underlying heart disease before ATE can occur. Regular veterinary examinations provide opportunity for detection of heart murmurs, arrhythmias, or other abnormalities that might indicate cardiac disease. For breeds with known cardiomyopathy predisposition, particularly Maine Coons and Ragdolls, screening echocardiography may be recommended even in the absence of clinical signs. Genetic testing for known mutations, such as those identified in Maine Coons (MyBPC3 mutation), can identify at-risk cats before disease develops. Annual cardiac auscultation with follow-up echocardiography for any detected abnormalities represents a reasonable screening approach for most cats, with more intensive monitoring for high-risk individuals.

Medical prevention of ATE in cats with known heart disease involves antithrombotic therapy to reduce clot formation risk. Clopidogrel (Plavix) is the most commonly recommended preventive medication, acting as an antiplatelet agent that reduces the ability of blood cells to form clots. Studies have shown that clopidogrel reduces ATE recurrence in cats that have survived an initial episode. Aspirin, another antiplatelet agent, has also been used but appears less effective than clopidogrel based on available evidence. Some cats may receive both medications. Anticoagulants such as low molecular weight heparins or newer oral anticoagulants are sometimes used, though optimal protocols are not established. The decision to initiate preventive antithrombotic therapy depends on the severity of heart disease and presence of risk factors.

Environmental and lifestyle modifications support prevention by reducing stress and optimizing overall health. Stress management is important because acute stress may trigger clot release in susceptible cats. Creating a calm, stable home environment with predictable routines helps reduce stress. For cats with significant heart disease, minimizing unnecessary stressors such as boarding, household disruption, or introduction of new pets may be advisable. Avoiding dehydration, which promotes blood clotting, is important. Maintaining appropriate body weight reduces cardiac workload. Indoor housing may reduce stress and exposure to triggers compared to outdoor access.

Health maintenance for cats at risk of ATE includes regular cardiac monitoring and optimization of heart disease treatment. Periodic echocardiography, typically every six to twelve months for cats with known heart disease, allows tracking of disease progression and adjustment of treatment. Blood pressure monitoring detects hypertension that may worsen cardiac function. Regular assessment of NT-proBNP levels may provide early warning of worsening heart disease. Maintaining optimal nutrition with appropriate levels of taurine, sodium, and other cardiac-relevant nutrients supports heart health. Prompt treatment of any intercurrent illness helps prevent decompensation.

Early intervention when warning signs appear can potentially prevent or minimize ATE events. Owners of cats with known heart disease should be educated about ATE symptoms and the need for immediate emergency care if they occur. Any subtle changes in a cardiac patient's condition, such as decreased activity, mild breathing changes, or reduced appetite, should prompt veterinary evaluation. Blood clot formation can be detected in some cats through echocardiography before an embolism occurs, allowing intensification of preventive therapy. Working closely with a veterinary cardiologist provides optimal management of high-risk cats and may reduce the likelihood of this devastating complication.

Daily management for cats recovering from or at risk for ATE involves consistent medication administration and monitoring for changes in condition. Cats typically require daily medication including cardiac drugs, antiplatelet agents, and possibly other medications depending on their specific situation. Establishing consistent medication routines helps ensure compliance and maintains therapeutic levels. Daily observation for subtle changes in breathing pattern, activity level, appetite, and behavior allows early detection of worsening heart disease or impending complications. For cats with residual limb deficits following ATE, daily assessment of limb function and comfort guides ongoing supportive care. Gentle range of motion exercises may be continued at home to maintain limb flexibility.

Home environment modifications support both safety and quality of life for cats with cardiac disease and ATE history. Reducing environmental stressors through maintaining consistent routines, providing hiding places, and avoiding unnecessary disruption helps keep cats calm. Easy access to food, water, and litter boxes on a single level prevents the need for strenuous climbing or jumping in cats with limited mobility or cardiac compromise. Soft, easily accessible resting spots allow comfortable rest. Temperature management ensures a warm, comfortable environment, as cats with circulatory compromise may be sensitive to cold. For cats with significant mobility impairment, ramps or steps to favorite resting spots, non-slip flooring, and confined spaces for safety during absence may be helpful.

Maintaining quality of life for cats living with heart disease and ATE risk involves balancing medical management with normal feline activities and enjoyment. Despite their medical condition, many affected cats can continue to enjoy gentle play, interaction with family members, grooming, and quiet companionship. Adjusting activity levels to the cat's tolerance helps prevent overexertion while maintaining quality of life. Monitoring for signs of discomfort or distress guides adjustments to care. Comfortable rest, appropriate nutrition, and freedom from pain are essential components of quality of life. Cats recovering from ATE may need modified expectations, but many adapt remarkably well and can enjoy meaningful quality of life.

Ongoing monitoring and regular veterinary care are essential for cats with cardiac disease and ATE history. Recheck appointments typically occur every three to six months, or more frequently if the cat's condition is unstable, and include physical examination, cardiac auscultation, and often echocardiography to track disease progression. Blood tests monitor kidney function and other parameters that may be affected by disease or medications. Blood pressure measurement detects hypertension. Medication adjustments are made based on clinical status and monitoring results. Owners should maintain communication with the veterinary team between scheduled visits, reporting any concerns promptly.

Caregiver support resources help owners navigate the challenges of managing a cat with serious cardiac disease and ATE risk. The emotional burden of caring for a cat with life-threatening illness can be significant, and owners should not hesitate to discuss their concerns with the veterinary team. Understanding the condition, its prognosis, and what to expect helps owners cope with uncertainty and make informed decisions. Financial considerations may be substantial given the cost of emergency care, ongoing medications, and regular monitoring. Preparing for potential emergencies by identifying the nearest emergency veterinary facility and keeping contact information accessible provides some peace of mind. Discussing end-of-life considerations in advance, while difficult, helps ensure the cat's welfare remains the priority should the condition deteriorate.

Certain cat breeds face elevated risk for aortic thromboembolism due to their predisposition to the underlying cardiomyopathies that cause this condition. Maine Coon cats have a well-documented increased risk for hypertrophic cardiomyopathy, with an identified genetic mutation (in the MYBPC3 gene) present in approximately 30 percent of the breed. Ragdoll cats similarly carry a different mutation in the same gene that predisposes to HCM. Both breeds should be considered high risk for ATE and benefit from cardiac screening and monitoring. British Shorthair cats appear to have increased HCM prevalence. Persian and Himalayan cats, Sphynx, Devon Rex, and Birman breeds have all been noted to have higher cardiomyopathy rates in various studies, though genetic causes are not as well characterized.

Beyond specific breed predispositions, other cat populations face increased ATE risk based on various factors. Any cat with diagnosed cardiomyopathy, regardless of breed, faces ATE risk proportional to disease severity and left atrial size. Middle-aged male cats are overrepresented in ATE cases, though this likely reflects the demographics of HCM rather than an independent risk factor. Domestic shorthair and longhair cats, due to their large population, account for a substantial number of ATE cases despite lower per-cat risk compared to predisposed breeds. Cats with echocardiographic findings of left atrial enlargement, particularly those with spontaneous echocardiographic contrast visible in the atrium, face the highest risk regardless of breed.

Screening recommendations for breeds and cats at risk include cardiac evaluation protocols tailored to risk level. For high-risk breeds such as Maine Coons and Ragdolls, genetic testing for known mutations is recommended, particularly for breeding cats. Echocardiographic screening beginning at one to two years of age allows early detection of cardiomyopathy, with repeat screening annually or as recommended by a cardiologist. For cats of predisposed breeds that test negative for known mutations or are of breeds without identified mutations, periodic echocardiography remains advisable given that mutations may exist that have not yet been identified. Breeders should screen breeding stock and avoid breeding cats with significant cardiomyopathy. Pet owners acquiring kittens from predisposed breeds should request documentation of parental cardiac screening and genetic testing where available.

Several conditions commonly co-occur with aortic thromboembolism due to the shared underlying cardiac disease that predisposes to multiple complications. Congestive heart failure is present in approximately 50 percent of cats at the time of ATE diagnosis, as the same cardiac abnormalities that promote clot formation also lead to fluid accumulation in or around the lungs. Cardiac arrhythmias, including atrial fibrillation and ventricular ectopy, are common in cats with the types of heart disease that cause ATE. Hypertension may co-occur with cardiac disease and contribute to cardiac dysfunction. Azotemia (elevated kidney values) may result from reduced cardiac output, concurrent kidney disease, or ischemic kidney injury from emboli affecting renal blood flow.

Conditions with similar symptoms that must be differentiated from ATE include other causes of acute hind limb paralysis or weakness. Spinal cord trauma from accidents or falls can cause sudden paralysis, but limbs remain warm with palpable pulses. Intervertebral disc disease, though less common in cats than dogs, can cause acute neurological deficits. Spinal tumors typically cause more gradual onset. Severe diabetic neuropathy causes hind limb weakness with a characteristic plantigrade stance. Hypokalemic myopathy, seen in cats with kidney disease or other causes of potassium depletion, causes generalized weakness rather than the acute localized paralysis of ATE. The characteristic finding of cold, pulseless limbs distinguishes ATE from these neurological conditions.

Potential complications of ATE extend beyond the immediate circulatory crisis. Reperfusion injury, which occurs when blood flow returns to ischemic tissue, causes release of toxic substances including potassium, myoglobin, and inflammatory mediators that can cause life-threatening complications including cardiac arrhythmias and acute kidney injury. Chronic complications in survivors may include muscle contracture, permanent weakness or paralysis of affected limbs, and auto-amputation of severely ischemic digits or limb portions. Recurrent thromboembolism affects a substantial percentage of survivors despite preventive therapy. Progressive heart disease continues to be the underlying threat, with potential for worsening heart failure, additional thromboembolic events, or sudden cardiac death.